Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities, alongside diet and physical activity
Members will continue to have access to GLP-1s when clinically appropriate and will benefit from coordinated, multidisciplinary supportwhether their treatment involves GLP-1s or other weight-management strategies
J Nutr Sci Vitaminol 64(3):229232 Ichikawa Y, Bayeva M, Ghanefar M, Potini V, Sun L, Mutharasan RK, Wu R, Khechaduri A, Jairaj Naik T, Ardehali H (2012) Disruption of ATP-binding cassette B8 in mice leads to cardiomyopathy through a decrease in mitochondrial iron export
Our testers found that the printing on their oral syringes faded quickly from exposure to the medicine, which eventually made it impossible to measure doses accurately
Hims reviews most patients within about a week, and branded fulfillment adds time after the prescription is written